Free Trial
NYSE:CC

Chemours (CC) Stock Price, News & Analysis

$24.32
+0.43 (+1.80%)
(As of 07/26/2024 ET)
Today's Range
$23.48
$24.50
50-Day Range
$22.11
$28.93
52-Week Range
$15.10
$38.58
Volume
1.11 million shs
Average Volume
1.59 million shs
Market Capitalization
$3.62 billion
P/E Ratio
N/A
Dividend Yield
4.11%
Price Target
$30.38

Chemours MarketRank™ Stock Analysis

Analyst Rating
Hold
2.38 Rating Score
Upside/​Downside
24.9% Upside
$30.38 Price Target
Short Interest
Healthy
3.43% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.38mentions of Chemours in the last 14 days
Based on 8 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
56.35%
From $1.81 to $2.83 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.42 out of 5 stars

Basic Materials Sector

84th out of 175 stocks

Chemicals & Allied Products Industry

9th out of 15 stocks

CC stock logo

About Chemours Stock (NYSE:CC)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for electronics, communications, transportation, wire and cable, energy, oil and gas, and medical, and other applications under the eflon, Viton, Krytox, and Nafion brands. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.

CC Stock Price History

CC Stock News Headlines

Chemours Company
“Generational Bull Run” Incoming
LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.
Chemours Announces Third Quarter Dividend
Chemours Rises as UBS Upgrades Stock To 'Buy'
“Generational Bull Run” Incoming
LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.
Chemours Publishes 2023 Sustainability Report
See More Headlines
Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/30/2024
Ex-Dividend for 6/14 Dividend
5/14/2024
Dividend Payable
6/14/2024
Today
7/26/2024
Next Earnings (Confirmed)
8/01/2024
Ex-Dividend for 9/13 Dividend
8/15/2024
Dividend Payable
9/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
Chemicals
Fax
N/A
Employees
6,200
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$30.38
High Stock Price Target
$40.00
Low Stock Price Target
$25.00
Potential Upside/Downside
+24.9%
Consensus Rating
Hold
Rating Score (0-4)
2.38
Research Coverage
8 Analysts

Profitability

Net Income
$-238,000,000.00
Pretax Margin
-7.26%

Debt

Sales & Book Value

Annual Sales
$6.03 billion
Cash Flow
$5.16 per share
Book Value
$4.98 per share

Miscellaneous

Free Float
148,195,000
Market Cap
$3.62 billion
Optionable
Optionable
Beta
1.80
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives


CC Stock Analysis - Frequently Asked Questions

How have CC shares performed this year?

Chemours' stock was trading at $31.54 on January 1st, 2024. Since then, CC stock has decreased by 22.9% and is now trading at $24.32.
View the best growth stocks for 2024 here
.

How were Chemours' earnings last quarter?

The Chemours Company (NYSE:CC) posted its quarterly earnings data on Tuesday, April, 30th. The specialty chemicals company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.07. Chemours's revenue was down 12.1% on a year-over-year basis.

What is Mark Vergnano's approval rating as Chemours' CEO?

106 employees have rated Chemours Chief Executive Officer Mark Vergnano on Glassdoor.com. Mark Vergnano has an approval rating of 85% among the company's employees.

Who are Chemours' major shareholders?

Top institutional investors of Chemours include Vaughan Nelson Investment Management L.P. (1.90%), Bank of New York Mellon Corp (1.08%), Folger Nolan Fleming Douglas Capital Management Inc. (0.45%) and Retirement Systems of Alabama (0.12%). Insiders that own company stock include Sameer Ralhan, Mark Newman, Edwin C Sparks, Alisha Bellezza, Matthew S Abbott, Alvenia Scarborough, Denise Dignam and David C Shelton.
View institutional ownership trends
.

How do I buy shares of Chemours?

Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Chemours investors own include AT&T (T), Pfizer (PFE), DuPont de Nemours (DD), NVIDIA (NVDA), Cisco Systems (CSCO), Micron Technology (MU) and Intel (INTC).

This page (NYSE:CC) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners